NCT01691742 - MiraLAX Versus Placebo to Prevent Constipation Following Urogynecologic Surgery | Biotech Hunter

Enrollment

131

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

April 30, 2015

Conditions

Post Procedural Constipation

Interventions

DRUG

MiraLax

MiraLax 17g powder daily for 5 days postoperatively following urogynecologic surgery

DRUG

Placebo

Placebo maltodextrin 17g powder daily for 5 days postoperatively following urogynecologic surgery

DRUG

Rescue Laxative

All participants will be instructed to take Milk of Magnesia with standard over-the-counter dosing as a recue laxative if the subject has not had a bowel movement by postoperative day 6.

Trial Locations (1)

27707

Duke University, Department of Urogynecology, Durham